Clinical Trials Directory

Trials / Sponsors / Astellas Institute for Regenerative Medicine

Astellas Institute for Regenerative Medicine

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central V
Age-Related Macular Degeneration
Phase 12018-07-13
Enrolling By InvitationA Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Ce
Macular Degenerative Disease
Phase 1 / Phase 22018-01-08
WithdrawnStudy to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
Age-Related Macular Degeneration
Phase 22015-08-24
CompletedLong Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD
Age-Related Macular Degeneration
—2013-02-25
CompletedA Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic S
Stargardt's Macular Dystrophy
—2013-01-16
CompletedLong Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Pa
Stargardt's Macular Dystrophy
—2012-07-11
CompletedSafety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented
Stargardt's Macular Dystrophy
Phase 1 / Phase 22011-12-13
CompletedSub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Stargardt's Macular Dystrophy
Phase 1 / Phase 22011-06-16
CompletedSafety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With
Dry Age Related Macular Degeneration
Phase 1 / Phase 22011-06-09